These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18240981)

  • 1. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.
    Braitstein P; Boulle A; Nash D; Brinkhof MW; Dabis F; Laurent C; Schechter M; Tuboi SH; Sprinz E; Miotti P; Hosseinipour M; May M; Egger M; Bangsberg DR; Low N;
    J Womens Health (Larchmt); 2008; 17(1):47-55. PubMed ID: 18240981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
    Tuboi SH; Brinkhof MW; Egger M; Stone RA; Braitstein P; Nash D; Sprinz E; Dabis F; Harrison LH; Schechter M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):52-9. PubMed ID: 17460471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.
    ; Keiser O; Anastos K; Schechter M; Balestre E; Myer L; Boulle A; Bangsberg D; Touré H; Braitstein P; Sprinz E; Nash D; Hosseinipour M; Dabis F; May M; Brinkhof MW; Egger M
    Trop Med Int Health; 2008 Jul; 13(7):870-9. PubMed ID: 18373510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) rationing and access mechanisms and their impact on youth ART utilization in Malawi.
    Dixon JG; Gibson S; McPake B; Maleta K
    Malawi Med J; 2011 Jun; 23(2):48-54. PubMed ID: 23074812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.
    Muula AS; Ngulube TJ; Siziya S; Makupe CM; Umar E; Prozesky HW; Wiysonge CS; Mataya RH
    BMC Public Health; 2007 Apr; 7():63. PubMed ID: 17459154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006.
    Stengaard AR; Lazarus JV; Donoghoe MC; Nielsen S; Matic S
    AIDS Care; 2009 Jul; 21(7):893-902. PubMed ID: 20024746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of treatment access in a population-based cohort of HIV-positive men and women living in Argentina.
    Zala C; Rustad CA; Chan K; Khan NI; Beltran M; Warley E; Ceriotto M; Druyts EF; Hogg RS; Montaner J; Cahn P;
    Medscape J Med; 2008 Apr; 10(4):78. PubMed ID: 18504475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.
    Firnhaber C; Smeaton L; Saukila N; Flanigan T; Gangakhedkar R; Kumwenda J; La Rosa A; Kumarasamy N; De Gruttola V; Hakim JG; Campbell TB
    Int J Infect Dis; 2010 Dec; 14(12):e1088-92. PubMed ID: 20961784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
    Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
    AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
    Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
    Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.
    Nicastri E; Leone S; Angeletti C; Palmisano L; Sarmati L; Chiesi A; Geraci A; Vella S; Narciso P; Corpolongo A; Andreoni M
    J Antimicrob Chemother; 2007 Oct; 60(4):724-32. PubMed ID: 17715125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to HAART in HIV-infected immigrants: a retrospective multicenter Italian study.
    Saracino A; El-Hamad I; Prato R; Cibelli DC; Tartaglia A; Palumbo E; Pezzoli MC; Angarano G; Scotto G;
    AIDS Patient Care STDS; 2005 Sep; 19(9):599-606. PubMed ID: 16164386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
    Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.
    King WD; Minor P; Ramirez Kitchen C; Oré LE; Shoptaw S; Victorianne GD; Rust G
    J Epidemiol Community Health; 2008 Sep; 62(9):798-803. PubMed ID: 18701730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.
    Jevtović D; Dragovic G; Salemović D; Ranin J; Kušić J; Marinković J; Djurković-Djaković O
    Biomed Pharmacother; 2014 Apr; 68(3):391-5. PubMed ID: 24486106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
    Sow PS; Otieno LF; Bissagnene E; Kityo C; Bennink R; Clevenbergh P; Wit FW; Waalberg E; Rinke de Wit TF; Lange JM;
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):262-7. PubMed ID: 17146376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.
    Frentz D; Boucher CA; van de Vijver DA
    AIDS Rev; 2012; 14(1):17-27. PubMed ID: 22297501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.